Humana and Evolent Expand Partnership to Enhance Oncology Care
Humana Inc. (NYSE:
HUM) and Evolent Health, Inc. (NYSE:
EVH) announced they have expanded their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services. By connecting all primary approaches to treating cancer, this collaboration will help expedite approval of prior authorization requests, improve patient access to care, and ensure timely access to critical treatments.
